Disease | parathyroid carcinoma |
Comorbidity | C0020437|hypercalcaemia |
Sentences | 2 |
PubMedID- 22188427 | hypercalcaemia due to parathyroid carcinoma presenting in the third trimester of pregnancy. |
PubMedID- 25949409 | The drug was also approved for the treatment of hypercalcaemia in patients with a parathyroid carcinoma at the recommended oral starting dose of 30 mg once daily. |
Page: 1